Standout Papers

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis ... 2012 2026 2016 2021 1.2k
  1. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study (2012)
    Patrick Marcellin, Edward Gane et al. The Lancet

Immediate Impact

2 by Nobel laureates 4 from Science/Nature 82 standout
Sub-graph 1 of 18

Citing Papers

Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
2025 Standout
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
1 intermediate paper

Works of G. Germanidis being referenced

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
2012 Standout

Author Peers

Author Last Decade Papers Cites
G. Germanidis 1356 1265 176 25 1.6k
S. Magrin 898 1002 134 43 1.4k
Franco Noventa 1226 1242 193 19 1.6k
J.M. Sánchez-Tapias 1594 1657 128 27 1.9k
Luigi Roffi 1277 1416 266 42 1.8k
Michele Gambardella 966 775 130 27 1.3k
Kyu Sik Jung 1378 1167 185 36 1.6k
Miharu Hirakawa 901 1048 74 42 1.2k
Consuelo Soldevila‐Pico 1498 1381 352 41 2.0k
G. Ronchi 1257 1182 261 36 1.6k
Tetsuya Ichijo 1121 1096 285 44 1.6k

All Works

Loading papers...

Rankless by CCL
2026